Marine-Derived Compounds Against WHO Critical Priority Fungal Pathogens Candida albicans and Candidozyma auris: Recent Advances in Antifungal Research (2021–2026)
The increasing incidence of fungal infections caused by Candida albicans and the multidrug-resistant emerging pathogen Candidozyma auris (formerly Candida auris) represents a major global healthcare challenge. Current antifungal therapies are limited by toxicity, drug–drug interactions, rapid resistance emergence, and...